Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications
Cancers · 09.07.2026 · 18 (14) · 2210
DOI: 10.3390/cancers18142210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 09.07.2026. Verfasst von Fatemeh Sadat Tabatabaei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Mass General Brigham, Boston, MA 02129, USA. Die Arbeit nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rare subtypes of gastroesophageal malignancies represent a small but biologically meaningful fraction of upper gastrointestinal cancers. Although most therapeutic algorithms are derived from conventional squamous cell carcinoma and adenocarcinoma, uncommon entities such as variants of squamous cell carcinoma, lymphoepithelioma-like carcinoma, adenosquamous carcinoma, neuroendocrine carcinoma, and others display distinct clinicopathologic, immunologic, and molecular features that may influence prognosis and therapeutic decision-making. This review synthesizes current evidence regarding the epidemiology, histopathology, molecular alterations, and emerging therapeutic vulnerabilities across these rare subtypes. Importantly, these tumors frequently exhibit aggressive clinical behavior and are often managed by extrapolation from more common histologies due to the absence of prospective data. Increasing integration of genomic profiling, immune characterization, and biomarker-driven stratification is essential to refine diagnoses, expand precision therapeutic strategies, and improve outcomes. Recognition of these rare subtypes in routine practice is critical, as even small molecularly defined populations may carry disproportionate biological and translational significance within oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Mass General Brigham, Boston, MA 02129, USA.
- Harvard Medical School, Boston, MA 02115, USA.
- Department of Pathology, Mass General Brigham, Boston, MA 02114, USA.
- Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- School of Medicine, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
- Department of Surgery, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
ORCID-Profile: Nicholas J Caldwell, Nattaya Teeyapun, Seyed Mohammad Amin Dashti, Jonathan N Glickman, Samuel J Klempner
Zitieren
APA
Tabatabaei, F. S., Caldwell, N. J., Teeyapun, N., Dashti, S. M. A., Durbin, S. M., Strickland, M., Glickman, J. N., & Klempner, S. J. (2026). Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications. Cancers, 18(14), 2210. https://doi.org/10.3390/cancers18142210
Vancouver
Tabatabaei FS, Caldwell NJ, Teeyapun N, Dashti SMA, Durbin SM, Strickland M, et al. Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications. Cancers. 2026;18(14):2210. doi:10.3390/cancers18142210
BibTeX
@article{Tabatabaei2026,
author = {Tabatabaei, Fatemeh Sadat and Caldwell, Nicholas J and Teeyapun, Nattaya and Dashti, Seyed Mohammad Amin and Durbin, Sienna M and Strickland, Matthew and Glickman, Jonathan N and Klempner, Samuel J},
title = {Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications},
journal = {Cancers},
year = {2026},
volume = {18},
number = {14},
pages = {2210},
doi = {10.3390/cancers18142210}
}
EUVIMED